Natera is the global leader in the development of blood-based diagnostics and has built considerable momentum in the utilization of our Signatera (tumor informed) and Latitude (tumor naïve) assays. Year 2025 reflected a significant increase in the utilization of Signatera with >700k samples processed across our labs. Our WGS/WES repertoire and the integration of Foresight’s phased variants technique and expertise in Lymphomas has enabled Natera to offer the most utilized, published, and studied MRD test available with global research. In addition, our best-in-class MRD assays combined with ultra-sensitivity have positioned Natera to lead this innovative area within diagnostics. Our business model has adapted and expanded to offer our customers with real world data and insights to support their research objectives. We believe that multi-time point molecular data, matched with curated clinical data from the EHR and matched H&E digital pathology provides our customers with the most biologically informed dataset for Oncology. These insights are ideally suited to support translational and clinical development teams with the evidence necessary to improve trial design, select the right patients and understand the correlation across treatments, outcomes and molecular signatures and MRD / ctDNA. In addition, our multi-modal datasets are uniquely designed to understand response, quantify resistance and build models defining recurrence and the time horizons when high risk patients with relapse/recur. Natera’s Mission for Life Science Companies: Integrate and utilize Natera’s portfolio of products, services and solutions to transform the R&D methodology and improve the probability of success across all of pharma’s primary verticals (Discovery, Development & Commercial) while bringing new products to market faster while compressing costs.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director